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Abstract
The sporadic emergence of New Delhi metallo-b-lactamase-1 (NDM-1)-producing Acinetobacter spp. has been reported in China; how-
ever, NDM-1-positive bacteria epidemics are rarely reported in intensive care units (ICUs) in China, or even in the world. During
15 months’ surveillance Acinetobacter spp. isolated from patients, heathcare workers and surfaces of a Chinese ICU were screened for
the blaNDM-1 gene. A total of 27 of 3114 Acinetobacter spp. strains were NDM-1 positive and identified as A. pittii with sequence type 63
(ST63) by multilocus sequence typing. Of the 27 NDM-1-positive A. pittii strains, 22 were isolated from the ICU surfaces and grouped
into a major clone A using pulsed-field gel electrophoresis typing, while the other five strains isolated from the patients were classified
into three clones (A, B and C). The blaNDM-1 gene was located on a 45-kb plasmid for all three A. pittii clones. The plasmid could be
transferred to A. pittii and A. baumannii recipients at both 30 and 37C but not to Escherichia coli J53. The plasmid could not be classified
into any of the known plasmid incompatibility groups. The blaNDM-1 region in the plasmid was flanked by two insertion sequence ele-
ments, ISAba125 and ISAba11, and no other carbapenemase gene was present in this NDM-1-positive A. pittii isolate. Thus, we present
the first report on the transmission and characterization of NDM-1-producing A. pittii in an ICU in China as well as a novel blaNDM-1
gene-bearing plasmid.
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Introduction
The emergence and worldwide dissemination of New Delhi
metallo-b-lactamase-1 (NDM-1)-producing pathogens in both
humans and the environment have created a major therapeu-
tic challenge for clinicians and attracted significant public
health attention [1–4]. As nosocomial pathogens, Acinetobac-
ter spp. are becoming a major concern because of their rapid
development of resistance to a wide range of antimicrobials.
The emergence of NDM-1-producing Acinetobacter spp. has
been recently reported in many countries, such as India,
Israel, Egypt, Germany, Spain, Switzerland, the United Arab
Emirates and China [5–12]. Interestingly, blaNDM-1 has been
shown to be a chimeric gene constructed by the fusion of
the aminoglycoside resistance gene aphA6 with a mannin-
binding lectin (MBL) gene, an event that probably occurred in
Acinetobacter spp. [13]; hence, Acinetobacter spp. are the likely
origin of this gene. A. baumannii was the most common
NDM-1-producing Acinetobacter spp. and the blaNDM-1 gene
was mostly chromosome located [8,14]. NDM-1-producing
A. lwoffii isolates were recently reported in China, and two
novel blaNDM-1 gene-bearing plasmids were sequenced and
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identified [15]. The blaNDM-1 gene is located within a com-
posite transposon flanked by two insertion elements of
ISAba125 in the pNDM-BJ01 plasmid [15].
Acinetobacter pittii, previously called Acinetobacter genomic
species (gen. sp.) 3, is increasingly recognized as a clinically
important taxa within the Acinetobacter calcoaceticus–A. bau-
mannii complex [16]. A. pittii is ecologically diverse and is
found in food, soil, and both clinically ill and healthy individu-
als [17,18]. Although accumulating evidence has shown that
it is closely associated with nosocomial infection, A. pittii has
historically been less recognized due to its absence of a for-
mal binomial name and clear-cut differentiating phenotypic
characteristics [19]. Several sequencing-based typing methods
have recently been provided to help with discrimination
between A. pittii and A. baumannii, including rpoB gene
sequencing, multilocus sequence typing (MLST) and 16S–23S
rRNA gene intergenic spacer sequencing [20,21].
Acinetobacter spp. are some of the most prevalent Gram-
negative bacteria isolated in China, particularly in intensive
care units (ICUs), and they share a high prevalence of exten-
sive drug-resistance [22]. Four A. baumannii isolates with the
blaNDM-1 gene were identified in four different provinces in
China in 2010 [9], shortly after the emergence of many
NDM-1-producing isolates within Enterobacteriaceae in India,
Pakistan and the UK [2]. The blaNDM-1 gene has been
increasingly detected in clinical non-baumannii Acinetobacter
spp. such as Acinetobacter lwoffii, Acinetobacter Junii and A. pittii,
as well as A. lwoffii of food animal origin [15,23–25]. A recent
study showed that nine of 726 non-baumannii Acinetobacter
spp. collected from 28 provinces in China contained the
blaNDM-1 gene, while three of the nine NDM-1-producing iso-
lates were A. pittii [26]. These findings have raised awareness
of the emergence and spread of NDM-1-carrying bacteria in
China. However, little is known about the epidemiology and
transmission of NDM-1-producing Acinetobacter spp. in clini-
cal hospital wards in China. Here we examined the transmis-
sion of multidrug-resistant Acinetobacter spp. in an ICU of a
tertiary care hospital in Beijing, China, from April 2008 to
July 2009 and then investigated and analysed the dissemina-
tion and characterization of NDM-1-producing Acinetobacter
spp. isolates.
Methods
Ethics statement
The study was approved by the Institutional Ethic Commit-
tees of the Academy of Military Medical Sciences and Chi-
nese PLA General Hospital. Written consent was obtained
from all patients before the study commenced.
Settings and patients
The ICU was located within a 3000-bed tertiary care hospital
in Beijing, China, and consisted of 18 beds in one large room
and two single-bed rooms. Most critically ill patients in this
ICU had been transferred from the surgical departments of
this hospital. ICU surfaces, including floors and tables, were
disinfected with electrolyzed acid water thrice daily.
Sample collection and strain identification
The samples included the clinical specimens from potentially
infected sites, such as sputum, urine and blood, and swabs
from the anterior nares, forehead, groins and axillae of all
patients in the ICU were collected within 24 h of admission
and every other day thereafter. Swab samples were also col-
lected from the surfaces near patients and work areas (e.g.
bedrails, equipment buttons, bed sheets, chart files, water
taps, drawer handles, dispensing tables and nurses’ station
desks) once every 4 days. An open blood plate was used to
collect samples from the air in a designated ward location at
a height of 1.5 m for half an hour. In the meantime, health-
care workers were also screened for Acinetobacter spp. using
swab samples from the anterior nares and hands once every
2 days.
Screened swabs and clinical specimens were inoculated on
blood plates. Colonies resembling Acinetobacter spp. on the
plates were isolated and transferred onto a China-Blue lac-
tose agar plate (Luqiao, Beijing, China) to select Gram-nega-
tive bacteria. The Acinetobacter spp. were further identified
according to their morphological and growth characteristics
using the oxidase, triple sugar iron and citrate tests [27]. To
discriminate A. pittii from A. baumannii, the RNA polymerase
b-subunit (rpoB) gene of the isolates was sequenced accord-
ing to the method described previously [28].
Molecular detection of NDM-1 and other resistance
determinants
Bacterial DNA was extracted using the Wizard7 genomic
DNA purification kit. The blaNDM-1 gene was detected by
polymerase chain reaction (PCR) using the primers NDM-1F:
5¢-GAAGCTGAGCACCGCATTAG and NDM-1R: 5¢-
GGGCCGTATGAGTGATTGC. The primers were designed
using the PRIMER3 web site (http://frodo.wi.mit.edu/primer3)
according to GenBank database entry FN396876. PCR condi-
tions were as follows: 95C for 5 min; 30 cycles of 95C for
30 s, 56C for 30 s, and 72C for 40 s, followed by 72C for
5 min. Carbapenemase determinants including blaOXA-51-like,
blaOXA-23-like, blaOXA-24-like, blaOXA-58-like, blaIMP-like and blaVIM-
like were detected according to the method described previ-
ously [29,30]. All PCR products were confirmed by sequenc-
ing and comparison with GenBank entries.
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Antimicrobial susceptibility testing
The minimum inhibitory concentrations were measured using
the agar dilution method or the Etest (AB bioMe´rieux, Solna,
Sweden). The results were interpreted according to the
interpretive standards of the Clinical Laboratory Standards
Institute (CLSI) [31]. Imipenem-ethylenediaminetetraacetic
acid synergy tests were performed using the MBL E-test to
screen MBL production according to the manufacturer’s
instructions. Escherichia coli ATCC 25922 and Pseudomonas
aeruginosa ATCC 27853 were used as the control strains for
antimicrobial susceptibility testing.
Genotyping
Multilocus sequence typing was performed as described on
the INSTITUT PASTEUR web site (http://www.pasteur.fr/
recherche/genopole/PF8/mlst/Abaumannii). The DNA
sequences were uploaded into the MLST database, and the
allelic numbers and sequence types (STs) were obtained
online. Pulsed-field gel electrophoresis (PFGE) was used to
determine the genetic relatedness of the Acinetobacter spp.
isolates as previously described [32].
Plasmid analysis and Southern blot
Whole genomic DNA including the plasmid of the isolates
was digested with 20 U of S1 nuclease at 37C for 20 min
and then separated by PFGE. The DNA fragments were then
transferred to positively charged nylon membranes (Roche
Applied Sciences, Penzberg, Germany). Hybridization was
conducted using DIG Easy Hyb Granules (Roche Applied Sci-
ences) at 64C, while detection was performed using a DIG
Nucleic Acid Detection Kit (Roche Applied Sciences).
Conjugation test
NDM-1-positive A. pittii D186 (clone A by PFGE typing),
H699 (clone B) and H924 (clone C) strains were used as the
donors. Sodium azide-resistant E. coli J53, NDM-1-negative
A. pittii D484 and A. baumannii H775 strains (sensitive to me-
ropenem but resistant to ciprofloxacin) were used as the
recipients, respectively. To select the transconjugants on
China-Blue lactose agar plate, meropenem (20 mg/L) in com-
bination with sodium azide (170 mg/L) was used for the
E. coli J53 strain or meropenem (20 mg/L) in combination
with ciprofloxacin (10 mg/L) was used for the D484 and
H775 strains.
Genome sequencing, plasmid analysis
Whole genome sequencing of NDM-1-positive A. pittii D499
was performed using Illumina HiSeq 2000 (Accession:
AGFH00000000.1; Illumina Inc., San Diego, CA, USA). The
procedures for functional annotation were performed as
described previously [23]. The plasmid sequences were
annotated by the RAST Server [33], and each predicted pro-
tein was further compared against the NCBI non-redundant
protein database using BLASTP [34]. To identify the plasmid
type, the complete sequences of the pAP-D499 plasmid were
investigated using BLASTX analysis and in silico PCR using the
system developed for the PCR-based replicon typing method
of A. baumannii [35].
Results
From 7 April 2008 to 7 July 2009, 3114 Acinetobacter spp.
were isolated: 1655 strains from patients, 104 strains from
healthcare workers, and 1355 strains from the ICU surfaces.
A total of 1149 of the 3114 isolates (36.9%) were imipenem
resistant, and 27 of these 1149 isolates (2.3%) were NDM-1
positive, including two strains isolated from patient fore-
heads, three strains isolated from patient groins, and 22
strains isolated from ICU surfaces (Table 1). All 27 of these
strains were identified as sequence type 63 (ST63) by MLST
and A. pittii using a VITEK 2 GN card and rpoB gene sequenc-
ing. Remarkably, NDM-1-positive A. pittii strains were never
isolated from the healthcare workers’ swab samples or the
patients’ sputum, urine or blood samples.
As shown in Figs 1 and 2, the A. pittii clone A (PFGE typing)
existed at the beginning of the surveillance in April 2008. This
clone somehow became NDM-1 positive on June 11 2008
and disseminated within this ICU, affecting the surfaces of
buttons, tables and water taps, and even the air (Table 1).
After 2 months’ dissemination in the environment, A. pittii
clone A was detected on the foreheads of the two patients
who had stayed sequentially in the same bed, indicating a pos-
sible vector-based transmission of NDM-1-positive A. pittii
(Table 1); however, this strain was never detected again.
Nine months later, NDM-1-producing A. pittii clone B (strain
H699) emerged on a patient’s groin on 6 May 2009. One
month later, another NDM-1-positive A. pittii clone C was
isolated twice from the fourth patient’s groin during his ICU
stay from 5 May to 18 June 2009 (Table 1; Fig. 2).
Of the total of 518 patients who stayed in the ICU for at
least 2 days during the 15-month study period, 116 (22.4%)
received carbapenems. Meropenem was most frequently
used (81 patients; 15.6% of the total), followed by imipenem
(37 patients; 7.1% of the total). The mean age of the 518
patients was 59 years (range, 1–97 years) and 184 (35.5%) of
them were female. The median length of stay in the ICU was
6 days (range, 2–277 days). A total of 450 patients (86.9%)
underwent surgery after their hospital admission, while 63
patients (12.2%) underwent ventilator support during their
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ICU hospitalization. The ages of the four patients who car-
ried NDM-1-positive A. pittii were 60–82 years. The first
three patients stayed in the ICU for around a week, but the
last patient stayed much longer, approximately 45 days.
Remarkably, none of these patients received carbapenems.
The underlying diseases of these four patients included uri-
nary retention, cervical cancer, gastric cancer, sepsis and
multiple organ failure.
TABLE 1. Distribution and antibiotic susceptibilities of New Delhi metallo-b-lactamase-1 (NDM-1)-positive Acinetobacter pittii
isolates of sequence type 63
Order of
isolating Strains no.
Date of
isolating Source of sample PFGE type
Minimal inhibitory concentration (mg/L)
CTX IMP MEM AK LEV COL MN
1 D039 2008-6-11 Bed 7 Button A 512 >32 >32 16 2 1 <0.125
2 D129 2008-6-21 Dispensing table A 512 >32 >32 4 2 2 <0.125
3a D147 2008-6-23 Water tap A 512 24 >32 8 2 2 <0.125
3b D151 2008-6-23 Bed 6 Button A 512 >32 >32 16 2 2 <0.125
3c D153 2008-6-23 Bed 7 Button A 512 >32 >32 16 1 4 <0.125
4 D163 2008-6-25 Air A 512 >32 >32 4 0.5 4 <0.125
5a D185 2008-6-27 Air A 512 >32 >32 16 1 2 <0.125
5b D186 2008-6-27 Drawer handle A 512 >32 >32 8 1 4 <0.125
6a D225 2008-7-1 Air A 512 >32 >32 16 2 4 <0.125
6b D228 2008-7-1 Water tap A 512 >32 >32 16 2 4 <0.125
7 D240 2008-7-3 Air A 512 >32 >32 16 2 1 <0.125
8 D265 2008-7-5 Dispensing table A 512 >32 >32 16 2 4 <0.125
9a D286 2008-7-7 Water tap A 512 >32 >32 16 2 2 <0.125
9b D287 2008-7-7 Dispensing table A 512 >32 >32 16 2 4 <0.125
9c D293 2008-7-7 Bed 6 Chart file A 512 >32 >32 8 1 2 <0.125
9d D294 2008-7-7 Bed 7 Chart file A 512 >32 >32 8 2 2 <0.125
9e D298 2008-7-7 Bed 4 Chart file A 512 >32 >32 8 2 2 <0.125
10 D321 2008-7-9 Chair A 512 >32 >32 16 2 2 <0.125
11a D330 2008-7-11 Air A 512 >32 >32 8 1 2 <0.125
11b D335 2008-7-11 Nurse’s station desk A 512 >32 >32 16 2 2 <0.125
11c D336 2008-7-11 Air A 512 >32 >32 8 2 4 <0.125
12 D353 2008-7-17 Air A 512 >32 >32 16 2 4 <0.125
13 D424 2008-8-6 Patient 1 Forehead A 512 >32 >32 8 1 4 <0.125
14 D499 2008-8-12 Patient 2 Forehead A >512 >32 >32 8 1 2 <0.125
15 H699 2009-5-6 Patient 3 Groin B 512 >32 >32 8 2 4 <0.125
16 H924 2009-6-13 Patient 4 Groin C 512 >32 >32 4 0.25 4 0.25
17 H944 2009-6-17 Patient 4 Groin C 512 >32 >32 8 0.25 4 0.25
CTX, cefotaxime; IMP, imipenem; MEM, meropenem; AK, amikacin; LEV, levofloxacin; COL, colistin; MN, minocyclin.
FIG. 1. The distribution of the New Delhi metallo-b-lactamase-1 (NDM-1)-positive and NDM-1-negative Acinetobacter pittii isolates with identical
pulsed-field gel electrophoresis (PFGE) type. The thick lines indicate the NDM-1-positive isolates; the thin lines indicate the NDM-1-negative iso-
lates. Three strain types existed in the intensive care unit before the blaNDM-1-carrying plasmid was acquired. NDM-1-positive A. pittii isolates
with PFGE type A had an outbreak from June to August 2008, while NDM-1-positive A. pitti isolates with PFGE type B and C emerged sporadi-
cally.
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According to CLSI 2012 [31], all of the NDM-1-positive
isolates were resistant to cefotaxime, imipenem, meropenem
and ertapenem and susceptible to amikacin, levofloxacin and
minocycline. Interestingly, nearly half of the NDM-1-positive
isolates (n = 13) showed colistin resistance (Table 1). The
OXA-type and other MBL carbapenemase genes, such as
blaOXA-51-like, blaOXA-23-like, blaOXA-24-like, blaOXA-58-like, blaVIM-like
and blaIMP-like, were not detected in any of the NDM-1-positive
A. pittii isolates.
Plasmid analysis and southern blot showed that the
blaNDM-1 gene was located on an approximate 45-kb plasmid.
This blaNDM-1-carrying plasmid was considered unstable in
the host because it was lost when the plasmid-carrying strain
was cultured on a Mueller-Hinton agar plate for only one
passage. This plasmid could be transferred to an NDM-1-
negative A. pittii recipient (D484) and an A. baumannii recipi-
ent (H775) by in vitro conjugation at both 30 and 37C, but
it could not be transferred to E. coli J53. All transconjugants
exhibited high-level resistance to carbapenems after plasmid
acquisition (Table 2).
The draft genome sequence of the NDM-1-positive A. pittii
D499 strain included an approximate 4-mb chromosome and
an approximate 45-kb NDM-1-carrying plasmid (named
pAP-D499) [23]. In silico analysis showed that the plasmid
pAP-D499 contained 55 open reading frames (ORFs) with an
average 40.8% GC content. The pAP-D499 plasmid pos-
sessed a putative transfer and replication region containing
the traA and traC plasmid transfer genes, the plasmid-parti-
tioning parA gene, and a type IV secretion system (T4SS)
gene cluster region. It could not be classified according to
replicase typing using in silico PCR [35]. None of the 55
ORFs, including 28 hypothetical proteins, was similar to any
of the current identified replicases by BLASTP. Only amino-
glycoside resistance gene aphA6 and bleomycin resistance
gene bleMBL were identified in this blaNDM-1-bearing plasmid.
No carbapenemase resistance genes other than blaNDM-1
were found in the D499 plasmid or chromosomes.
The blaNDM-1 region in the pAP-D499 plasmid was flanked
by two insertion sequence (IS) elements (ISAba125 and
ISAba11), a finding that differed from those of earlier reports
FIG. 2. Dendrogram of the pulsed-field gel electrophoresis patterns of some New Delhi metallo-b-lactamase-1 (NDM-1)-positive strains. Most
isolates were of identical strains and had the same pulsed-field gel electrophoresis (PFGE) pattern. Strain H699 is a different subtype, although
close genetic relatedness was observed between this strain and the strains isolated earlier. Strains H924 and H944 are distinct and have different
PFGE patterns.
TABLE 2. Characteristics of New Delhi metallo-b-lactamase-1 (NDM-1)-positive Acinetobacter pittii donors and transconju-
gants
Strain Species Grow at 44C PFGE type blaNDM-1
Conjugation
temperature
Minimal inhibitory concentra-
tion (mg/L)
IMP MEM CIP
D186 A. pittii ) A + N/A >32 >32 1
H699 A. pittii ) B + N/A >32 >32 2
H924 A. pittii ) C + N/A >32 >32 0.25
D484 A. pittii ) D ) N/A 1 1 64
D484–D186 A. pittii ) D + 30 & 37C >32 >32 64
D484–H699 A. pittii ) D + 30 & 37C >32 >32 64
D484–H924 A. pittii ) D + 30 & 37C >32 >32 64
H775 A. baumannii + E ) N/A 4 2 64
H775–D186 A. baumannii + E + 30 & 37C >32 >32 64
H775–H699 A. baumannii + E + 30 & 37C >32 >32 64
H775–H924 A. baumannii + E + 30 & 37C >32 >32 64
IMP, imipenem; MEM, meropenem; ETM, ertapenem; AK, amikacin; CIP, ciprofloxacin; N/A, not applicable.
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of A. lwoffii, A. pittii and A. baumannii [14,15,26]. The insertion
sequence element ISAba11, which had a length of 1101 bp,
represents an emerging insertion sequence family that
encodes transposases [36]. ISAba11 was bracketed by identi-
cal 5-bp direct repeats (attta), indicating target site duplica-
tion, and contained matching 13-bp terminal inverted repeat
(TIR). It shared 99% sequence identity with that identified in
A. baumannii strain ATCC 19606 and 98% sequence identity
with a hypothetical protein encoded by A. baumannii ATCC
17978 [36,37].
The genetic content in the blaNDM-1 region of the pAP-
D499 plasmid was nearly the same as described previously
(Fig. 3) [14,15], including the bleMBL gene, genes encoding the
GroES and GroEL chaperonin proteins, and the ISCR element
ISCR27 located downstream of blaNDM-1. The GroEL protein
(547 amino acids) and ISCR27 (399 amino acids) shared
100% identity with that encoded by the pNDM-BJ01 plasmid
from A. lwoffii [15].
Discussion
In China, scattered emergence of NDM-1-positive Acinetobac-
ter spp. has been reported, including A. baumanii, A. lwoffii
and A. pittii [9,15,24,26]. In this study, NDM-1-positive A. pittii
clone A disseminated predominantly within the ICU and was
detected in the air a remarkable seven times. This result
indicated that airborne transmission might contribute to the
spread of NDM-1-positive A. pittii, a finding that is in line
with those of earlier studies suggesting that airborne trans-
mission may be important in the spread of some Acinetobac-
ter species [38–40]. The lack of isolation of NDM-1-positive
A. pittii from the hands and anterior nares of healthcare
workers hinted that healthcare workers in this ICU might
not be vectors of NDM-1-positive A. pittii dissemination.
Stricter infection control practices such as environmental
cleaning and air hygiene may be required to reduce the
spread of NDM-1-positive A. pittii within the ICU.
The origin and spread of NDM-1-positive A. pittii in this
ICU remains vague. Compared with the report on the emer-
gence of NDM-1-positive bacteria in China, the NDM-1-posi-
tive A. pittii that emerged on 11 June 2008 was confirmed as
the first NDM-1-positive strain in China. All of the patients
and healthcare workers in the ICU during this period of time
were questioned, and no direct evidence showed any contact
with southwest Asia, especially India or Pakistan. The
recently reported dissemination of NDM-1-positive bacteria
in New Delhi and the detection of NDM-1 in the seepage
and tap water indicated that the natural reservoir of the
NDM-1 gene may play a critical role in the dissemination of
the NDM-1 gene throughout different bacteria [1]. Our preli-
minary data also showed the existence of the NDM-1 gene in
the sewage effluent samples in this hospital (data not shown).
Therefore, a detailed investigation into the origin and spread
of NDM-1-positive A. pittii in this ICU in the near future
would be of great interest.
It is known that multidrug-resistant A. baumannii is highly
prevalent in Chinese hospitals [41], whereas A. pittii epidem-
ics are rarely reported in ICUs in China [16]. This is likely
to be due to the fact that few studies have completely speci-
ated Acinetobacter spp. However, it is quite interesting that
all NDM-1-positive Acinetobacter spp. in the present study
were the A. pittii ST63 strain, whereas 126 non-ST63 type
Acinetobacter spp. were totally NDM-1 negative (data not
shown). These data suggested that NDM-1 was prevalent in
A. pittii but not A. baumannii during our surveillance, although
A. baumannii was the most prevalent multidrug-resistant clini-
cal microorganism during the same period and the blaNDM-1-
carrying plasmids could also be transferred to A. baumannii
recipients using an in vitro conjugation test (Table 2). It is dif-
ficult to explain the low incidence of NDM-1 in A. baumannii,
and the complicated clinical situation herein may contribute
to this phenomenon. Further detailed investigations into this
issue are needed.
The blaNDM-1-carrying plasmid in A. pittii was approxi-
mately 45 kb, much smaller than the blaNDM-1-carrying
FIG. 3. Features of the genetic environment of blaNDM-1 in the pAP-D499 plasmid. The target gene lengths and the exact target site location are
to scale. GC content is indicated in percentages. Gene names are abbreviated according to their corresponding proteins: aphA6 for aminoglyco-
side 3¢-phosphotransferase; iso for phosphoribosylanthranilate isomerase; tat for the twin-arginine translocation pathway signal sequence protein;
dct for the divalent cation tolerance protein; 4pac for truncated phospholipid acetyltransferase; and res for resolvase.
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plasmids in Enterobacteriaceae [1,2,9,15,42] but similar to
the blaNDM-1-carrying plasmids in A. baumannii strains isolated
in China in 2009 (30–50 kb) [9]. Although a relatively high
transfer frequency had been reported from NDM-1-positive
A. lwoffii to E. coli in a conjugation test [15], the inability of
this blaNDM-1-carrying plasmid to transfer into E. coli in our
study was in line with earlier reports in which no blaNDM-1-
carrying plasmids from A. baumannii could be transferred to
E. coli recipients and no plasmids of Enterobacteriaceae were
detected among NDM-1-producing A. baumannii [5].
Tn125 were recently shown to be the main vehicle for
the dissemination of blaNDM-1 genes in A. baumanii and
non-baumannii Acinetobacter spp. [14,26]. In our study, the
composite transposon containing blaNDM-1 in the plasmid
pAP-D499 was nearly identical to its counterpart in either of
the A. lwoffii plasmids isolated from China or chromosomes
of A. baumannii isolated from many European countries
[14,15], except that the insertion sequence ISAba11 instead
of ISAba125 located downstream of blaNDM-1 (Fig. 3). It was
recently shown that the ISAba11 elements belong to a novel
family that encodes transposases with a signature HHEK
motif and had been found in many kinds of Acinetobacter spp.
[36]. The ISAba11 in the pAP-D499 was associated with typi-
cal 5-bp DR and possessed 13-bp TIR as previously reported
[36]. ISAba11 movement can result in inactivation of the
A. baumannii lipid A biosynthesis genes lpxA and lpxC, result-
ing in the loss of lipopolysaccharide production and high-level
colistin resistance. However, no lpxA or lpxC elements were
found in pAP-D499, so the evolution of ISAba11 might differ
from that found in A. baumannii isolates [43]. The composite
transposon containing blaNDM-1 in pAP-D499 was probably
derived via recombination events between Tn125 and Tn11.
In a word, we characterized the dissemination of NDM-1-
positive A. pittii strains in an ICU in China and identified a
novel genetic structure containing the blaNDM-1 gene in Aci-
netobacter spp. Further investigations are required to track
the transmission pathways of blaNDM-1-carrying plasmids and
to understand the disseminative regularity of the blaNDM-1
gene in Acinetobacter spp. isolates.
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